WallStreetZenWallStreetZen

NASDAQ: DNTH
Dianthus Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Dianthus Therapeutics revenue was $2.04M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $284.0k, down 28.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DNTH annual revenue was $2.0M, with -67.3% growth year-over-year.

DNTH past revenue growth

How has DNTH's revenue growth performed historically?

Company
-67.35%
Industry
488.98%
Market
88.7%
DNTH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DNTH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

DNTH revenue history

Current Revenue
$2.0M
Current Earnings
-$162.3M
Current Profit Margin
-7,973.3%

Be the first to know when DNTH announces revenue.

DNTH Revenue History By Year

DNTH Yearly RevenueDNTH RevenueDNTH ChangeDNTH Revenue Growth
2025-12-31$2.04M-$4.20M-67.35%
2024-12-31$6.24M$3.41M+120.63%
2023-12-31$2.83M-$3.59M-55.96%
2022-12-31$6.42MN/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A

1 of 1

Dianthus Therapeutics Revenue FAQ

What was DNTH's revenue last quarter?

On Invalid Date, Dianthus Therapeutics (NASDAQ: DNTH) reported Q4 2025 revenue of $284.00 thousand up 78.58% year over year. In the same quarter last year, Dianthus Therapeutics's revenue was $1.33 million.

What was Dianthus Therapeutics's revenue in 2025?

Dianthus Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $2.04 million, a 67.35% decrease year over year.

How much does Dianthus Therapeutics make in a day?

Based on Dianthus Therapeutics annual revenue for the past five years, DNTH makes an average of $9,596.71 per day.

What was Dianthus Therapeutics's annual revenue growth in the past year?

As of Q1 2026, Dianthus Therapeutics's revenue has grown -67.35% year over year. This is 556.33 percentage points lower than the US Biotechnology industry revenue growth rate of 488.98%. Dianthus Therapeutics's revenue in the past year totaled $2.04 million.

How much does Dianthus Therapeutics make in a year?

Dianthus Therapeutics's revenue by year for the past five years is:
  • Dianthus Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $2.04 million, a 67.35% decrease year over year.
  • Dianthus Therapeutics's annual revenue for Dec 31, 2024 was $6.24 million, a 120.63% increase from 2023.
  • Dianthus Therapeutics's annual revenue for 2023 was $2.83 million, a 55.96% decrease from 2022.
  • Dianthus Therapeutics's annual revenue for 2022 was $6.42 million, a Infinity% increase from 2021.
  • Dianthus Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.